19/11/2019
QUB Shares In £1.25m Cancer Research Funding
Queen's University Belfast is to share in £1.25 million of funding to further prostate cancer research.
The money was awarded to local academics and those at The University of Manchester by Prostate Cancer UK and Movember.
It will be used to expand clinical trials, develop and pioneer novel treatments while enhancing expert knowledge of the aggressive cancer that affects one in eight men.
The funding follows a £5m investment from Prostate Cancer UK and Movember in 2014 to create the first regional Movember Centre of Excellence, a partnership between the two universities.
Prostate cancer is the most common cancer among males in the UK, with more than 47,500 new diagnoses every year.
Since the initiative (known as FASTMAN) began, researchers have developed new tests to identify high risk patients, and find which patients respond best to various treatment options.
Joe O'Sullivan, Professor of Radiation Oncology at the Centre for Cancer Research and Cell Biology at QUB, said recent developments include new tests to identify types of tumour and greater understandings of how radiotherapy can be used as a treatment.
He explained: "Through these new tests, we can potentially identify patients with particularly high risk prostate cancer to determine what treatment will be most effective, tailored to the particular tumour.
"We have also tested several new treatment options through clinical trials which have had encouraging results. We are currently planning to expand availability of these trials to eligible men across the nation. We are proud of the real successes to date and we are delighted to be able to continue this important work."
Simon Grieveson, Head of Research Funding at Prostate Cancer UK said: "Prostate cancer is the most commonly diagnosed cancer in men in the UK and sadly thousands of men die from this disease each year. There is still so much we don't know about this disease, and so investment into research is crucial if we are to improve the way prostate cancer is diagnosed and treated.
"Over the past five years the Belfast-Manchester Movember Centre of Excellence has brought together some of the world's leading researchers and clinicians, who have made huge strides in the investigation of new treatments and tests to help tackle prostate cancer.
"Which is why Prostate Cancer UK and Movember have extended our initial £5 million funding of the centre by an additional £1.25 million, so that the team can expand their work and continue to help us answer some of the most important questions in prostate cancer research."
The Bishop of Connor, the Rt Rev Alan Abernethy, was diagnosed with aggressive prostate cancer during a sabbatical in 2018, aged 62. Bishop Abernethy was asked to take part in the clinical trial led by Professor O'Sullivan and his team that used a new combination of existing cancer therapies for men with advanced prostate cancer. Bishop Abernethy recently completed his treatment when he also announced his retirement. He said: "The trial has given me the most amazing gift – the best possible treatment. I'm delighted that this trial is set to continue so that many more people can receive this treatment."
(JG/MH)
The money was awarded to local academics and those at The University of Manchester by Prostate Cancer UK and Movember.
It will be used to expand clinical trials, develop and pioneer novel treatments while enhancing expert knowledge of the aggressive cancer that affects one in eight men.
The funding follows a £5m investment from Prostate Cancer UK and Movember in 2014 to create the first regional Movember Centre of Excellence, a partnership between the two universities.
Prostate cancer is the most common cancer among males in the UK, with more than 47,500 new diagnoses every year.
Since the initiative (known as FASTMAN) began, researchers have developed new tests to identify high risk patients, and find which patients respond best to various treatment options.
Joe O'Sullivan, Professor of Radiation Oncology at the Centre for Cancer Research and Cell Biology at QUB, said recent developments include new tests to identify types of tumour and greater understandings of how radiotherapy can be used as a treatment.
He explained: "Through these new tests, we can potentially identify patients with particularly high risk prostate cancer to determine what treatment will be most effective, tailored to the particular tumour.
"We have also tested several new treatment options through clinical trials which have had encouraging results. We are currently planning to expand availability of these trials to eligible men across the nation. We are proud of the real successes to date and we are delighted to be able to continue this important work."
Simon Grieveson, Head of Research Funding at Prostate Cancer UK said: "Prostate cancer is the most commonly diagnosed cancer in men in the UK and sadly thousands of men die from this disease each year. There is still so much we don't know about this disease, and so investment into research is crucial if we are to improve the way prostate cancer is diagnosed and treated.
"Over the past five years the Belfast-Manchester Movember Centre of Excellence has brought together some of the world's leading researchers and clinicians, who have made huge strides in the investigation of new treatments and tests to help tackle prostate cancer.
"Which is why Prostate Cancer UK and Movember have extended our initial £5 million funding of the centre by an additional £1.25 million, so that the team can expand their work and continue to help us answer some of the most important questions in prostate cancer research."
The Bishop of Connor, the Rt Rev Alan Abernethy, was diagnosed with aggressive prostate cancer during a sabbatical in 2018, aged 62. Bishop Abernethy was asked to take part in the clinical trial led by Professor O'Sullivan and his team that used a new combination of existing cancer therapies for men with advanced prostate cancer. Bishop Abernethy recently completed his treatment when he also announced his retirement. He said: "The trial has given me the most amazing gift – the best possible treatment. I'm delighted that this trial is set to continue so that many more people can receive this treatment."
(JG/MH)
Related Northern Ireland News Stories
Click here for the latest headlines.
15 August 2024
Construction Begins On New Lidl In Coleraine
Construction has begun on the new 'Concept' Lidl store in Coleraine, marking the start of the supermarket chain's multimillion-pound initiative to revamp its retail estate throughout Northern Ireland. At least 18 new jobs will be created as part of a multi-million-pound local store investment, bringing the total team employed to 40.
Construction Begins On New Lidl In Coleraine
Construction has begun on the new 'Concept' Lidl store in Coleraine, marking the start of the supermarket chain's multimillion-pound initiative to revamp its retail estate throughout Northern Ireland. At least 18 new jobs will be created as part of a multi-million-pound local store investment, bringing the total team employed to 40.
25 July 2024
DUP Leader Urges Govt To Financially Support NI's Public Services
DUP Leader and East Belfast MP Gavin Robinson has urged the new Government to enhance financial support for public services and reform in Northern Ireland.
DUP Leader Urges Govt To Financially Support NI's Public Services
DUP Leader and East Belfast MP Gavin Robinson has urged the new Government to enhance financial support for public services and reform in Northern Ireland.
19 August 2024
Doug Beattie Resigns As UUP Leader
Doug Beattie has announced his resignation as leader of the Ulster Unionist Party (UUP), citing "irreconcilable differences" with party officers.
Doug Beattie Resigns As UUP Leader
Doug Beattie has announced his resignation as leader of the Ulster Unionist Party (UUP), citing "irreconcilable differences" with party officers.
26 July 2024
Henderson Retail Invests £5m In Three Coleraine Stores
Henderson Retail has completed the renovation and conversion of a former Spar store on Millburn Road in Coleraine into a new EuroSpar community supermarket. The 25-week project has increased the store size by 50% to 4,000 sq ft, added around 2,000 new lines and has created eight additional full-time positions.
Henderson Retail Invests £5m In Three Coleraine Stores
Henderson Retail has completed the renovation and conversion of a former Spar store on Millburn Road in Coleraine into a new EuroSpar community supermarket. The 25-week project has increased the store size by 50% to 4,000 sq ft, added around 2,000 new lines and has created eight additional full-time positions.
06 November 2024
Health Minister Backs Progressive Smoking Ban in New UK Bill
Health Minister Mike Nesbitt has welcomed the introduction of the Tobacco and Vapes Bill, which introduces a progressive smoking ban to gradually end the sale of tobacco products across the UK, so that anyone born on or after 1st January 2009 will never be able to legally be sold cigarettes.
Health Minister Backs Progressive Smoking Ban in New UK Bill
Health Minister Mike Nesbitt has welcomed the introduction of the Tobacco and Vapes Bill, which introduces a progressive smoking ban to gradually end the sale of tobacco products across the UK, so that anyone born on or after 1st January 2009 will never be able to legally be sold cigarettes.